Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation-Reference-Cited by-同舟云学术

Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation

Published:2019-10 Issue:4 Volume:74 Page:372-380
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Chang Hung-Yu,Feng An-Ning,Fong Man-Cai,Hsueh Chao-Wen,Lai Wei-Tsung,Huang Kuan-Chih,Chong Eric,Chen Chi-Nan,Chang Hung-Chuan,Yin Wei-Hsian

Funder

Cheng Hsin General Hospital Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Clinical epidemiology of heart failure;Mosterd;Heart,2007

2. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure;Bonneux;Am J Public Health,1994

3. Impending epidemic: future projection of heart failure in Japan to the year 2055;Okura;Circ J,2008

4. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);The CONSENSUS Trial Study Group;N Engl J Med,1987

5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of angiotensin receptor neprilysin inhibitor in improving cardiac function and blood pressure in dialysis patients;Frontiers in Medicine;2024-09-05

2. Sacubitril-Valsartan in Patients Requiring Hemodialysis;JAMA Network Open;2024-08-20

3. Effect of sacubitril/valsartan on hospital readmissions in heart failure with reduced ejection fraction in Saudi Arabia: A multicenter retrospective cohort study;Medicine;2024-07-26

4. Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis;Frontiers in Cardiovascular Medicine;2024-07-22

5. The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review;Indian Heart Journal;2024-07